Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia. Article uri icon

Overview

publication date

  • August 10, 2017

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological
  • Interleukin-3 Receptor alpha Subunit
  • Leukemia, Myeloid, Acute

Identity

PubMed Central ID

  • PMC5809236

Scopus Document Identifier

  • 85027137688

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1361023

PubMed ID

  • 28795850

Additional Document Info

volume

  • 59

issue

  • 4